Literature DB >> 25683185

Biosimilar biologics: never identical but close enough.

Rita Abi-Raad1, Brian R Smith.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 25683185     DOI: 10.1111/trf.12961

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  1 in total

1.  A pharmacokinetics phase 1 bioequivalence study of the trastuzumab biosimilar MYL-1401O vs. EU-trastuzumab and US-trastuzumab.

Authors:  Cornelius F Waller; Apinya Vutikullird; Tracey E Lawrence; Andrew Shaw; Mark Shiyao Liu; Mark Baczkowski; Rajiv Sharma; Abhijit Barve; Parag Goyal; Charles Donnelly; Nilanjan Sengupta; Eduardo J Pennella
Journal:  Br J Clin Pharmacol       Date:  2018-07-31       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.